BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1780043)

  • 41. Changes in levels of the tripeptide Tyr-Gly-Gly as an index of enkephalin release in the spinal cord: effects of noxious stimuli and parenterally-active peptidase inhibitors.
    Llorens-Cortes C; Gros C; Schwartz JC; Clot AM; Le Bars D
    Peptides; 1989; 10(3):609-14. PubMed ID: 2780419
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of acetorphan with clonidine for opiate withdrawal symptoms.
    Hartmann F; Poirier MF; Bourdel MC; Loo H; Lecomte JM; Schwartz JC
    Am J Psychiatry; 1991 May; 148(5):627-9. PubMed ID: 2018165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid beta and impairment of learning and memory.
    Mouri A; Zou LB; Iwata N; Saido TC; Wang D; Wang MW; Noda Y; Nabeshima T
    Behav Brain Res; 2006 Mar; 168(1):83-91. PubMed ID: 16360221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
    Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; Fournié-Zaluski MC
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of insulin degrading enzyme by racecadotril in the brain of Wistar rats.
    Lee JP; Cheng KC; Chung HH; Wu HT; Chen CT; Cheng JT
    Horm Metab Res; 2011 Jun; 43(7):489-93. PubMed ID: 21557151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor.
    Chaillet P; Marçais-Collado H; Costentin J; Yi CC; De La Baume S; Schwartz JC
    Eur J Pharmacol; 1983 Jan; 86(3-4):329-36. PubMed ID: 6572590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New carboxyalkyl inhibitors of brain enkephalinase: synthesis, biological activity, and analgesic properties.
    Fournié-Zaluski MC; Chaillet P; Soroca-Lucas E; Marçais-Collado H; Costentin J; Roques BP
    J Med Chem; 1983 Jan; 26(1):60-5. PubMed ID: 6298420
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acetorphan, an enkephalinase inhibitor, decreases gastric secretion in cats.
    Bado A; Chicau-Chovet M; Appia F; Dubrasquet M; Lecomte JM; Rozé C
    Peptides; 1987; 8(1):89-93. PubMed ID: 3554169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enkephalinase 'A' inhibition by thiorphan: central and peripheral cardiovascular effects.
    Baum T; Becker FT; Sybertz EJ; Sabin C; Desiderio DM
    Eur J Pharmacol; 1983 Oct; 94(1-2):85-91. PubMed ID: 6360696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enantiomers of [R,S]-thiorphan: dissociation of analgesia from enkephalinase A inhibition.
    Scott WL; Mendelsohn LG; Cohen ML; Evans DA; Frederickson RC
    Life Sci; 1985 Apr; 36(13):1307-13. PubMed ID: 2984500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An in vitro study on the hippocampal electrophysiological properties of enkephalinase inhibitors in rats.
    Proietti ML; Sagratella S; Frank C; Trampus M; Scotti de Carolis A
    Pharmacol Biochem Behav; 1991 May; 39(1):119-21. PubMed ID: 1924493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Penicillins exhibit enkephalinase inhibitory activity in mice.
    Livingston SJ; Williams PS; Sewell RD; Smith HJ
    Prog Clin Biol Res; 1990; 328():413-6. PubMed ID: 2304960
    [No Abstract]   [Full Text] [Related]  

  • 53. [Enkephelinase inhibitors acetorphan and SCH34826 potentiate the analgesic effect of low frequency electroacupuncture in rats].
    Zhou Y; Luo F; Han J
    Zhen Ci Yan Jiu; 1990; 15(4):310-4. PubMed ID: 2125896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analgesia produced by immobilization stress and an enkephalinase inhibitor in amphibians.
    Stevens CW; Sangha S; Ogg BG
    Pharmacol Biochem Behav; 1995 Aug; 51(4):675-80. PubMed ID: 7675842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inactivation of atrial natriuretic factor in mice in vivo: crucial role of enkephalinase (EC 3.4.24.11).
    Gros C; Souque A; Schwartz JC
    Eur J Pharmacol; 1990 Apr; 179(1-2):45-56. PubMed ID: 2142086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enkephalinase-blocking agent thiorphan affects cell growth and differentiation in long term culture of mouse bone marrow.
    Krizanac-Bengez L; Boranic M
    Biomed Pharmacother; 1995; 49(7-8):375-80. PubMed ID: 8562866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid Beta and impairment of learning and memory.
    Zou LB; Mouri A; Iwata N; Saido TC; Wang D; Wang MW; Mizoguchi H; Noda Y; Nabeshima T
    J Pharmacol Exp Ther; 2006 Apr; 317(1):334-40. PubMed ID: 16382024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel inhibitors of enkephalin-degrading enzymes. I: Inhibitors of enkephalinase by penicillins.
    Williams PS; Sewell RD; Smith HJ; Gonzalez JP
    J Enzyme Inhib; 1989; 3(2):91-101. PubMed ID: 2489237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Labelling and exploration of the active site of enkephalinase (EC 3.4.24.11) in kidney membranes with [3H]thiorphan as ligand.
    De la Baume S; Schwartz JC
    Eur J Pharmacol; 1988 Apr; 149(1-2):121-9. PubMed ID: 3165067
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intracerebroventricular met-enkephalin administration modulates adjuvant arthritis.
    Elhassan AM; Papadogiannakis N; Adem A; Suliman I; Gad A; Lindgren JU
    Brain Res; 2000 Oct; 879(1-2):23-8. PubMed ID: 11011002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.